Psychedelics - Areas of Support
Psychedelics have shown many benefits for several mental health conditions, especially those that have been resistant to traditional approaches. Here’s a brief overview of the conditions commonly addressed.
PTSD: MDMA-assisted therapy has been recognized as a breakthrough treatment, significantly reducing trauma symptoms, particularly in veterans and individuals with severe PTSD.
Depression: Psilocybin has shown positive results in alleviating symptoms of major depressive disorder, offering relief even after a single session.
Anxiety: Psychedelic therapy can decrease chronic anxiety and end-of-life distress, helping individuals experience greater peace and emotional stability.
Addiction: Psilocybin and other psychedelics have been used to treat addictions, disrupting destructive thought patterns and reducing substance use.
Obsessive-Compulsive Disorder (OCD): Initial research suggests psychedelics may help reduce obsessive thinking and compulsive behaviors, promoting more flexible thought patterns.
Trauma-Related Disorders: Psychedelic therapy can support processing and healing from complex trauma, offering new pathways to recovery.
Eating Disorders: Psychedelics are being explored for their potential to address eating disorders by reducing obsessive thoughts and improving emotional regulation.
* RESEARCH & PUBLICATIONS:
Psilocybin desynchronizes the human brain. Nature.com. Siegel, J.S., Subramanian, S., Perry, D. et al (2024).
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatry. Davis AK, Barrett FS, May DG, et al. (2021)
Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder. Journal of Psychedelic Studies. (2025, November 24)
Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report. Heliyon. Kelmendi B, Kichuk S, DePalmer G (2022, December)
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients. JAYMA Psychiatry. (2022, August 24)
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment. Bentham Science(2023, September 13)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. Griffiths, R.R., Richards, W.A., McCann, U. et al. (2006, July 07)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer. Arch Gen Psychiatry. Grob CS, Danforth AL, Chopra GS, et al. (2011)
Spontaneous and deliberate creative cognition during and after psilocybin exposure. Transl Psychiatry. Mason NL, Kuypers KPC, Reckweg JT, Müller F, Tse DHY, Da Rios B, Toennes SW, Stiers P, Feilding A, Ramaekers JG. (2021, April 8)
A single dose of psilocybin boosts neuroplasticity and reduces depression symptoms. Reported in PsyPost(2023). Link to published research included.